Why fire at Serum Institute of India's Pune plant has sent jitters across vaccine industry

The companies that are making COVID-19 vaccines can be highly vulnerable targets for cyber attacks and other sophisticated attempts of sabotage, say experts.

Viswanath Pilla
January 22, 2021 / 07:29 PM IST

Serum Institute of India, the world's largest vaccine maker, is already mass producing and stockpiling AstraZeneca's Covishield shot, while Indian biotech players Bharat Biotech and Zydus Cadila are developing their own vaccine candidates (Representative File Photo)

Even as the investigation is underway to find out the reasons for the breakout of fire on January 21 at Serum Institute of India (SII) vaccine factory in Pune that killed at least five people and gutted equipment worth hundreds of crores of rupees, experts and industry executives have expressed shock and called the fire incident of this scale  "unusual".

The fire broke out at a building that makes Rotavirus and BCG vaccines, near the company's existing production plant at Manjri, a Pune suburb, where vaccine manufacturing equipment was being installed for the upcoming production of non-COVID vaccines.

Adar Poonawalla, CEO of SII, told CNBC-TV18 that new product launches will be hit, and there will be major equipment damage and more than Rs 1000 crore in revenue loss over the next one to two years due to the fire.

Maharashtra Chief Minister Uddhav Thackeray tweeted that an "electrical fault" caused the fire at the plant.

To be sure, SII is the largest vaccine maker in the world by volume, with a strong track record of regulatory and quality compliance and industrial safety.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"If you have a facility where let's say an expansion or construction is going on -- this is a facility which has been producing rotavirus vaccine --  there could be some renovation, repair or expansion that might have been going on; we don't have exact details, but this (fire) is quite unusual," said Davinder Gill, former CEO of Hilleman Laboratories. Gill was previously global head of Biotherapeutics at Pfizer.

Gill explains that unlike the pharmaceutical industry, especially bulk drug units that have chemical reactors involving risky chemical reactions that are prone to fire accidents, vaccine facilities have bioreactors to grow microorganisms and are generally safe from a fire standpoint. But they also have tanks that hold solvents and buffers.

"The inflammable thing that vaccine manufacturing uses is ethanol (alcohol), and the manufacturers are trying to limit or eliminate the use of it," Gill said.

Ethanol is used as a solvent in certain vaccines like Haemophilus influenzae type B HIB, for precipitation of  DNA (or washing) in vaccine manufacturing.

Another top executive of a vaccine company who didn't want to be named said that he was surprised at the intensity of the fire.

"We still don't have details, electrical fault is claimed as a possible reason. Electric short circuits or build-up of static electricity can happen, but are rare," the executive said.

"This isn't any old legacy plant; it is a newly built state-of-the-art manufacturing site making WHO prequalified vaccines - there will be a fire safety plan. Even the workers couldn't escape from fire to safety is both sad and bizarre," the executive added.

Accident or Sabotage?

Experts say the companies that are making COVID-19 vaccines can be highly vulnerable targets for cyber attacks and other sophisticated attempts of sabotage.

"I think we have to be careful not to rush to conspiracy theories, but those investigating should examine the angle of sabotage, given the circumstances that we live in," Gill said.

The vaccine executive quoted above said that when he saw the visuals of the fire at the SII plant on TV, the first thing he did was to immediately call his relevant department head and instructed him to beef up the security at the plants.

"Security and surveillance at vaccine manufacturing plants are taken very seriously because we deal with biohazard material," the executive said.
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
TAGS: #Business #Companies #coronavirus #Health
first published: Jan 22, 2021 07:29 pm